Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility
December 16, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight after a roller-coaster week that mashed together three classic biotech ingredients: eye-popping early clinical data, a rapidly upsized stock offering, and a stack of Wall Street price-target hikes. As of 14:38 UTC on Tuesday (Dec. 16, 2025), Wave Life Sciences stock was trading at $16.94, up about 5.2% on the day, with an intraday range of $16.14 to $17.27, according to market data. What changed today: Oppenheimer raised its price target to $32 from $24 and reiterated an Outperform rating, pointing to what it called